Bioengineering Lantibiotics for Therapeutic Success
Open Access
- 27 November 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Microbiology
- Vol. 6, 1363
Abstract
Several examples of highly modified antimicrobial peptides have been described. While many such peptides are non-ribosomally synthesized, ribosomally synthesised equivalents are being discovered with increased frequency. Of the latter group, the lantibiotics continue to attract most attention. In the present review, we discuss the implementation of in vivo and in vitro engineering systems to alter, and even enhance, the antimicrobial activity, antibacterial spectrum and physico-chemical properties, including heat stability, solubility, diffusion and protease resistance, of these compounds. Additionally, we discuss the potential applications of these lantibiotics for use as therapeutics.Keywords
Funding Information
- Science Foundation Ireland (TIDA 14/TIDA/2286)
- SFI Investigator awards to CH and RR (10/IN.1/B3027)
- SFI-PI (11/PI/1137)
- Alimentary Pharmabiotic Centre (SFI/12/RC/2273)
This publication has 86 references indexed in Scilit:
- The Lantibiotic Peptide Labyrinthopeptin A1 Demonstrates Broad Anti-HIV and Anti-HSV Activity with Potential for Microbicidal ApplicationsPLOS ONE, 2013
- Activity of Gallidermin on Staphylococcus aureus and Staphylococcus epidermidis BiofilmsAntimicrobial Agents and Chemotherapy, 2012
- Nisin, an apoptogenic bacteriocin and food preservative, attenuates HNSCC tumorigenesis via CHAC1Cancer Medicine, 2012
- Chemical Synthesis and Biological Activity of Analogues of the Lantibiotic Epilancin 15XJournal of the American Chemical Society, 2012
- Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive PathogensAntimicrobial Agents and Chemotherapy, 2011
- In Vitro Mutasynthesis of Lantibiotic Analogues Containing Nonproteinogenic Amino AcidsJournal of the American Chemical Society, 2009
- Dissecting Structural and Functional Diversity of the Lantibiotic MersacidinChemistry & Biology, 2009
- Pharmacodynamic activity of the lantibiotic MU1140International Journal of Antimicrobial Agents, 2009
- Inhibition of Bacillus anthracis Spore Outgrowth by NisinAntimicrobial Agents and Chemotherapy, 2008
- Insights into In Vivo Activities of Lantibiotics from Gallidermin and Epidermin Mode-of-Action StudiesAntimicrobial Agents and Chemotherapy, 2006